Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: HEB, Hemispherx Biopharma (AMEX)NEW

08 Dec 2014 02:38 PM <--

05 Nov 1997 12:47 PM

Return to HEB, Hemispherx Biopharma (AMEX)NEW

All information on HEB and HEB warrants is up to date on the old thread, HEMX.
HEB recently listed on the AMEX, having traded before on NASDAQ. Ampligen, its primary drug, is currently in phase III
human clinical trials in the U.S.A. for treatment of CFS, chronic fatigue syndrome. This thread has been started
for the benefit of those searching for the new symbol, HEB, and posts on either thread are welcome.